Paid members5.7 millionCompany disclosure · Sep 29, 2026
Private financingMore than USD 900 millionPrivate financing · Oct 14, 2025
Private funding valuationApproximately USD 11 billionPrivate company valuation · Oct 14, 2025
- IPO filing
- Roadshow
- Pricing
- First trade
- Quiet period
- Lockup
Private valuation history
Dated private-company valuations · USD
Hover or tap to inspect values
$11B▲ +111.5% since first observationLatest observation · 2025 financing
- Private valuation
2024 Series D2024 Series D2025 financing2025 financing
First valuation$5.2B2024 Series D
Latest valuation$11B2025 financing
Observations22024 Series D – 2025 financing
Valuation change+111.5%since first observation
Use Left and Right arrows to select a data point. Home and End select the first and last. Tap to pin a selection; Escape or Reset clears it.
IPO recap
Offering not completed
Oura filed IPO documents on Sep 3, 2026. IPO date, ticker, and IPO offer price are not yet confirmed.
FiledSep 3
Pricing—
First trade—
Lockup ends—
The short version
Oura officially postponed its Nasdaq offering on 29 September 2026. The public filing provides company detail, while the former price range and launch timetable are historical.
Key takeaway 1
IPO officially postponed; no replacement date confirmed.
Key takeaway 2
September range and share count are historical preliminary terms.
Key takeaway 3
Paid members differ from cumulative device sales.
Company in detail
Oura combines a smart ring with membership services that translate sensor readings into health and wellness insights. Device purchases and continuing memberships have different economics. An investor needs to examine hardware demand, renewal behaviour and the cost of delivering the ongoing service together, while keeping the measures distinct.
Oura's September public registration brought a level of disclosure that private watchlist companies often lack. The initial filing reported five million paid members at 30 June 2026. The later postponement statement reported 5.7 million; both figures need their own dates and should not be confused with cumulative rings sold.
The preliminary prospectus dated 21 September described a 50-million-share offering, including 13.5 million new shares and 36.5 million shares from existing holders. It proposed a $40–44 range and the Nasdaq symbol OURA. These are terms of the subsequently paused offering, not a final public share price or evidence of trading.
On 29 September Oura officially postponed the IPO. No replacement date was confirmed in the material reviewed through 7 October. A postponement by itself does not establish formal withdrawal of the registration, so the distinction between filed disclosure and a live sale remains important.
Our assessment would focus on membership retention, hardware replacement cycles, gross margins and sensitive-data controls. A renewed offering would need current terms and financial disclosure. Private financing valuations should remain separate from the price investors may eventually be asked to pay.
Operating metrics
Paid members
5.0 millionProspectus measure at 30 June 2026; different from cumulative rings sold.
Jun 30, 2026Paid members
5.7 millionCompany figure in the postponement announcement; distinct from June's prospectus measure and cumulative ring sales.
Sep 29, 2026Company profile
- Legal name
- Oura, Inc.
- Founded
- 2013
- Origins
- Founded in Finland in 2013
- Headquarters
- San Francisco; EU headquarters Oulu
- CEO
- Tom Hale
- Proposed US issuer
- Oura, Inc.; 2026 corporate reorganisation
- Product
- Oura Ring and health-insight membership
- Health role
- Wellness wearable; Oura says it is not a medical device
- Employees
- No published figure
Timeline
- Series D
Raised USD 200 million at USD 5.2 billion private valuation.
- Private financing
Announced over USD 900 million at approximately USD 11 billion.
- Public S-1
Filed a public registration statement.
- IPO postponed
Officially postponed the IPO due to uncertainty in the IPO market.
- Preliminary offer terms
Proposed 50 million shares at USD 40–44, including 13.5 million primary shares. Historical preliminary terms of the subsequently postponed offering.
Paid members
5.7millionCompany figure in the postponement announcement; distinct from June's prospectus measure and cumulative ring sales.
Private financing
More than USD 900 millionCompany-announced financing; disclosed lower bound, not an exact amount.
Private funding valuation
Approximately USD 11 billionOctober 2025 private financing reference, not an IPO valuation.
Employees
—No published figure
Paid members
5.0millionProspectus measure at 30 June 2026; different from cumulative rings sold.
Operating cash flow
—No published figure
Financials
No complete financial history available
Revenue
Financial history unavailableComparable financial periods will appear here when available.
No comparable financial series
Available dated disclosures are included in the company overview. View disclosures →
Valuation & peers
Price-to-sales, revenue growth and gross margin
Comparable metrics unavailableComparable company figures for the same date are not available.
Revenue growth (%)
| Company | P/S | Growth | GM |
|---|---|---|---|
| Oura | — | — | — |
| No published peer comparison | |||
Context: Private financing valuations and modeled market values do not establish an IPO valuation. Revenue run-rate is not used here to calculate a price-to-sales ratio.
Private valuation and funding details
Private funding valuation
Approximately USD 11 billionOctober 2025 private financing reference, not an IPO valuation.
Private financing
More than USD 900 millionCompany-announced financing; disclosed lower bound, not an exact amount.
IpoHub score
How we score—Not rated
Balance sheet—
Growth—
Community—
Profitability—
Valuation—
Individual category scores are not available.
Where the money goes
—
Use of proceeds—
Allocation percentages—
Net proceeds—
Details on the use of IPO proceeds are not available.
Key risks
Editorial analysisHardware demand
Device cycles, manufacturing costs and returns affect the relationship between growth and cash generation.
Member retention
Our assessment would examine whether engagement and renewals support durable recurring revenue.
Sensitive data
Health-related information requires dependable privacy, security and product controls.
Deal terms
- Ticker
- Not confirmed
- Exchange
- Not confirmed
- IPO price
- Not confirmed
- Price range
- Not confirmed
- Pricing date
- Not confirmed
- First trading day
- Not confirmed
- Shares offered
- Not confirmed
- Deal size
- Not confirmed
- Underwriters
- Not confirmed
- Greenshoe shares
- Not confirmed
- Lockup
- Not confirmed
- Quiet period expirations
- Not confirmed
Oura IPO: where and how to invest
Where can I invest in the Oura IPO?
The Oura IPO is currently marked as filed; public share trading is not yet confirmed in this profile. If IPO subscriptions become available, you need a broker offering that specific deal to investors in your country. Having an account does not guarantee an allocation. After a confirmed listing, you can look for a broker that supports the relevant exchange.
Can I buy Oura shares now?
Public trading in Oura shares is not yet confirmed here. An announced or priced offering does not automatically mean you can buy the stock on an exchange. An IPO subscription and a private share purchase each have separate access requirements.
When is the Oura IPO?
A confirmed first trading day for Oura has not yet been published here. Check official company announcements and final offering documents; a planned timetable can change.
What is the Oura IPO share price?
A confirmed IPO offer price for Oura has not yet been published here. Private funding valuations and modeled private-market prices do not establish the eventual IPO share price.
What is Oura's stock ticker and exchange?
A stock ticker for Oura has not yet been confirmed here. An exchange has not yet been confirmed here. A proposed symbol or exchange does not establish that trading has begun. Verify the final listing announcement before placing an order.
Can I buy Oura shares before the IPO?
Private transactions or funds may sometimes provide exposure to Oura if a specific offer exists and you meet its requirements. This profile does not confirm an available private offer. A fund interest may provide indirect exposure rather than direct ownership of company shares. Private investments can have resale restrictions, uncertain valuations and limited exit options; a future IPO is not guaranteed.
Where can I find the Oura IPO prospectus?
Check Oura's official investor-relations announcements and publications from the relevant regulator and exchange. A confidential submission or an announcement about it is not a publicly available prospectus. Before subscribing, read the final prospectus for the risks, price, share class and offering terms.
More questions about the Oura IPO
Is Oura's IPO scheduled?
Oura officially postponed the offering on 29 September 2026; no new date was confirmed by 7 October.
Is $40–44 the current share price?
No. It was a preliminary range before the postponement, not a final priced IPO.
Are OURA shares trading?
The proposed Nasdaq symbol does not establish that the listing or first trade occurred.
Do paid members equal rings sold?
No. Membership is a continuing customer measure; ring sales count devices sold over a specified period.
Similar IPOs
All IPOs →Not investment advice. Private market prices are dated model estimates. Community votes are not a recommendation.